By fusing Sartorius’ expertise in bioprocessing and life sciences with NVIDIA’s AI-driven computing platforms and software, the two companies are extending their multidisciplinary partnership to support the creation of novel and improved medicines.
“Biological relationships are incredibly intricate. Increasing data utilization through the integration of AI solutions and life science knowledge is a viable strategy to streamline and expedite biopharmaceutical drug discovery and production. Prof. Dr. Oscar-Werner Reif, Chief Technology Officer of Sartorius, stated that “this expanded collaboration with NVIDIA will help result in relevant technological innovations for our customers and ultimately for patients.”
Since 2020, Sartorius has collaborated with NVIDIA. By incorporating NVIDIA’s technology into its instruments, the life science group has made edge computing applications of its live-cell imaging platform possible for lab-based commercialized AI experiments.
The partnership has concentrated on creating AI models of stem cell-derived organoids that are predictive in order to replace animal models in precision medicine and drug discovery. Sartorius is also utilizing simulation tools and NVIDIA technologies for predictive bioprocess design in the production of novel medicines.
Concerning the Extended Partnership
As part of the extended partnership, the Sartorius ecosystem will use the NVIDIA Clara suite of AI-powered computing platforms, applications, and services more frequently. Plans call for developing and releasing strong fundamental models that leverage the vast and distinctive data sets of Sartorius.
Through the NVIDIA DGX platform and the NVIDIA Clara suite, Sartorius customers will also have access to new predictive AI models, tools, and simulations for a variety of application domains.
In order to create innovative therapeutic agents and therapies, the cooperation will investigate a number of cutting-edge technologies, such as computer-based design and modeling of intricate 3D-bioprinted spheroids and organoids or synthetic biological pathways and organisms built based on Sartorius cell lines.
